Iparomlimab and Tuvonralimab: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
4
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| BRAF V600 Colorectal Cancer | 1 |
| Breast cancer | 1 |
| Colorectal cancer | 1 |
| HR-positive/HER2-negative Breast Cancer | 1 |
Recruiting trials involving Iparomlimab and Tuvonralimab
- Neoadjuvant QL1706 in Patients With Hormone Receptor Positive, HER2-negative Breast Cancer
- Safety and Efficacy of IB-FOLFIRI in BRAF V600E-Mutant Metastatic Colorectal Cancer
Common questions
How many recruiting trials involve Iparomlimab and Tuvonralimab?
2 recruiting trials across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.